These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 33684630

  • 1. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS, Gill J, Todd HF, Yang MB, Lopez MA, Abid F, Lotze T, Shah VS.
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [Abstract] [Full Text] [Related]

  • 2. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, Dimachkie M.
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [Abstract] [Full Text] [Related]

  • 3. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ, Ying G.
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM, Hussein MA, Lee AG, Paysse EA, Chandran R, Coats DK.
    Binocul Vis Strabismus Q; 2002 Oct; 17(3):181-6. PubMed ID: 12171588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S, Panichai P, Liumsuwan S.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S, Borchert M.
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [Abstract] [Full Text] [Related]

  • 9. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM.
    J Neurol Sci; 2004 Feb 15; 217(2):131-3. PubMed ID: 14706214
    [Abstract] [Full Text] [Related]

  • 10. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ, Latkany R, Homel P.
    Arch Neurol; 2003 Feb 15; 60(2):243-8. PubMed ID: 12580710
    [Abstract] [Full Text] [Related]

  • 11. Visual and systemic outcomes in pediatric ocular myasthenia gravis.
    Pineles SL, Avery RA, Moss HE, Finkel R, Blinman T, Kaiser L, Liu GT.
    Am J Ophthalmol; 2010 Oct 15; 150(4):453-459.e3. PubMed ID: 20678749
    [Abstract] [Full Text] [Related]

  • 12. Myasthenia gravis in Jamaican children: a 12-year institutional review.
    Melbourne Chambers R, Forrester S, Gray R, Tapper J, Trotman H.
    Paediatr Int Child Health; 2012 Feb 15; 32(1):47-50. PubMed ID: 22525448
    [Abstract] [Full Text] [Related]

  • 13. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT.
    JAMA Neurol; 2015 Oct 15; 72(10):1170-4. PubMed ID: 26258604
    [Abstract] [Full Text] [Related]

  • 14. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L, Castro D, Reisch JS, Iannaccone ST.
    Muscle Nerve; 2020 Feb 15; 61(2):226-230. PubMed ID: 31650555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
    Bi Z, Ge H, Zhang Q, Gao H, Yang M, Zhan J, Lin J, Gui M, Li Y, Ji S, Cao Y, Bu B.
    Pediatr Neurol; 2023 Sep 15; 146():31-39. PubMed ID: 37421800
    [Abstract] [Full Text] [Related]

  • 17. Pediatric Ocular Myasthenia Gravis.
    Fisher K, Shah V.
    Curr Treat Options Neurol; 2019 Sep 26; 21(10):46. PubMed ID: 31559492
    [Abstract] [Full Text] [Related]

  • 18. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA, Scala S, Jones HR.
    Muscle Nerve; 2010 Mar 26; 41(3):379-84. PubMed ID: 19918767
    [Abstract] [Full Text] [Related]

  • 19. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N, Sigg B, Melms A, Weller M, Schepelmann K, Herzau V, Dichgans J.
    J Neurol Neurosurg Psychiatry; 1997 Feb 26; 62(2):156-62. PubMed ID: 9048716
    [Abstract] [Full Text] [Related]

  • 20. Diplopia in a patient presenting with "blurred vision": a case report.
    Harrison A, Mudhar O, Yoo J, Rampal M.
    J Med Case Rep; 2023 Sep 08; 17(1):402. PubMed ID: 37679826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.